David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 75,000 shares at $54.62 ($4.1M) on 2014-11-26, disclosed to the SEC on 2014-12-01.
Open-market sale of $4.1M CPHD by EVP, Chief Med/Tech Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |
| CPHD | SELL | 2014-10-31 | $1.1M | — | Filing → |